stockrowAbbott Laboratories
ABT Healthcare Medical Devices
Abbott Laboratories' revenue for fiscal 2025 (year ended December 2025) was $44.3 billion, up 5.67% from fiscal 2024.
- Revenue
- +14.5%
- EPS
- −43.6%
- Free cash flow
- +28.9%
- Total debt
- +140.8%
Quarter to September 2026, against a year earlier
Follow ABT
Alert me
Abbott Laboratories (ABT) Gross margin
Abbott Laboratories's gross margin over the twelve months to 30 September 2026 was 56.9%, up 0.5 percentage points from fiscal 2025 (56.4%). Over the past ten years it has ranged from 54.7% (fiscal 2017) to 58.5% (fiscal 2019); the current reading is higher than 55% of that period. That is in line with the Medical Devices industry median of 57.8% and above the Healthcare sector median of 53.9%.
Gross margin, annual
Embed this chart
Annual newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| FY2025 | 56.4% | 1.01 |
| FY2024 | 55.4% | 0.23 |
| FY2023 | 55.2% | (0.97) |
| FY2022 | 56.2% | (0.82) |
| FY2021 | 57.0% | 0.32 |
| FY2020 | 56.7% | (1.88) |
| FY2019 | 58.5% | 0.08 |
| FY2018 | 58.5% | 3.75 |
| FY2017 | 54.7% | (1.69) |
| FY2016 | 56.4% | (0.74) |
Quarterly newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| Sep 2026 | 56.8% | (0.96) |
| Jun 2026 | 57.7% | 1.51 |
| Mar 2026 | 56.2% | (0.85) |
| Dec 2025 | 57.1% | 1.69 |
| 43 more quarters | Free account |
Against its own ten years
Gross margin against peers
| Company | Gross margin |
|---|---|
| EW Edwards Lifesciences Corporation compare | 78.0% |
| BSX Boston Scientific Corporation compare | 69.1% |
| SYK Stryker Corporation compare | 65.3% |
| MDT Medtronic PLC compare | 65.0% |
| DXCM DexCom, Inc. compare | 63.4% |
| ABT Abbott Laboratories | 56.9% |
| PHG Koninklijke Philips N.V. compare | 46.4% |
| STE STERIS plc compare | 44.6% |
| GEHC GE HealthCare Technologies Inc. compare | 40.0% |
| Medical Devices industry median | 57.8% |
| Healthcare sector median | 53.9% |
| Market median | 45.1% |
What Gross margin is
Gross Margin tells an investor how much of each sale a company keeps after paying the direct costs of making or buying what it sells.
Gross Profit ÷ Revenue
More on ABT
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement